Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (261-270 of 752) with videos related to

Pageof 76
Sort By:
Wiener Klinische Wochenschrift|October 24, 2023
Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary interventionAchim Leo Burger, Nora Beran, Edita Pogran, et al.
Journal of Interventional Cardiology|September 29, 2011
The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countriesAndrea Rubboli, Willem Dewilde, Kurt Huber, et al.
Clinical Chemistry|July 26, 2011
Admission proinsulin is associated with mortality in patients with admission hyperglycemia during acute coronary syndrome: results from a pilot observational studySerdar Farhan, Rudolf Jarai, Ioannis Tentzeris, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 24, 2024
Management of dyslipidaemia in patients with comorbidities-facing the challengeLisa Frühwald, Peter Fasching, Dobromir Dobrev, et al.
Journal of Leukocyte Biology|January 5, 2024
Decreased percentages of plasmacytoid dendritic cells predict survival in critically ill patientsEva Steinacher, Max Lenz, Konstantin A Krychtiuk, et al.
Atherosclerosis Plus|October 9, 2023
The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndromeEdita Pogran, Paul M Haller, Claudia Wegberger, et al.
The American Journal of Medicine|January 22, 2019
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Journal of the American Heart Association|May 20, 2017
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) StudyJay Shavadia, Robert Welsh, Anthony Gershlick, et al.
Thrombosis and Haemostasis|November 5, 2005
Interleukin-1 gene cluster variants and abdominal aortic aneurysmsRodrig Marculescu, Gottfried Sodeck, Hans Domanovits, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 5, 2020
Application of the fourth universal definition of myocardial infarction in clinical practiceJohannes Mair, Louise Cullen, Evangelos Giannitsis, et al.
Pageof 76

Showing results (261-270 of 752) with videos related to

Sort By:
Pageof 76
Wiener Klinische Wochenschrift|October 24, 2023
Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary interventionAchim Leo Burger, Nora Beran, Edita Pogran, et al.
Journal of Interventional Cardiology|September 29, 2011
The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countriesAndrea Rubboli, Willem Dewilde, Kurt Huber, et al.
Clinical Chemistry|July 26, 2011
Admission proinsulin is associated with mortality in patients with admission hyperglycemia during acute coronary syndrome: results from a pilot observational studySerdar Farhan, Rudolf Jarai, Ioannis Tentzeris, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 24, 2024
Management of dyslipidaemia in patients with comorbidities-facing the challengeLisa Frühwald, Peter Fasching, Dobromir Dobrev, et al.
Journal of Leukocyte Biology|January 5, 2024
Decreased percentages of plasmacytoid dendritic cells predict survival in critically ill patientsEva Steinacher, Max Lenz, Konstantin A Krychtiuk, et al.
Atherosclerosis Plus|October 9, 2023
The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndromeEdita Pogran, Paul M Haller, Claudia Wegberger, et al.
The American Journal of Medicine|January 22, 2019
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Journal of the American Heart Association|May 20, 2017
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) StudyJay Shavadia, Robert Welsh, Anthony Gershlick, et al.
Thrombosis and Haemostasis|November 5, 2005
Interleukin-1 gene cluster variants and abdominal aortic aneurysmsRodrig Marculescu, Gottfried Sodeck, Hans Domanovits, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 5, 2020
Application of the fourth universal definition of myocardial infarction in clinical practiceJohannes Mair, Louise Cullen, Evangelos Giannitsis, et al.
Pageof 76